Search Results - Brown, Chris, MBiostats

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial

    Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial by Kneebone, Andrew, Prof, Fraser-Browne, Carol, BA, Duchesne, Gillian M, Prof, Fisher, Richard, PhD, Frydenberg, Mark, Prof, Herschtal, Alan, PhD, Williams, Scott G, Prof, Brown, Chris, MBiostats, Delprado, Warick, Prof, Haworth, Annette, Prof, Joseph, David J, Prof, Martin, Jarad M, Prof, Matthews, John H L, MBChB, Millar, Jeremy L, Prof, Sidhom, Mark, MBBS, Spry, Nigel, Prof, Tang, Colin I, MBBS, Turner, Sandra, MBBS, Wiltshire, Kirsty L, MBBS, Woo, Henry H, Prof, Davis, Ian D, Prof, Lim, Tee S, MBBS, Pearse, Maria, MBChB

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

    ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance by Itchins, Malinda, BMedSci, M.B.B.S., FRACP, PhD, Liang, Shirley, BSc, Brown, Chris, MBiostats, BSc, Barnes, Tristan, BSc (Med), M.B.B.S., FRACP, Marx, Gavin, BSc, M.B.B.S., FRACP, Chin, Venessa, M.B.B.S., FRACP, PhD, Kao, Steven, BHB, MBChB, PhD, FRACP, Yip, Po Yee, MBChB, FRACP, PhD, Mersiades, Antony J., BMedSc, M.B.B.S., FRACP, MMed (Clin. Epi), Nagrial, Adnan, M.B.B.S., FRACP, PhD, Bray, Victoria, M.B.B.S., FRACP, PhD, Peters, Geoffrey, BPharm, M.B.B.S., FRACP, Parakh, Sagun, BSc, MBChB, FRACP, PhD, Garg, Kavita, PhD, Li, Bob T., MD, PhD, MPH, McKay, Matthew, PhD, O'Byrne, Kenneth, M.B.B.S., FRACP, FRCPA, MD, John, Thomas, M.B.B.S., FRACP, PhD, Gill, Anthony J., MD, FRCPA, Molloy, Mark P., PhD, Solomon, Benjamin J., M.B.B.S., FRACP, PhD, Pavlakis, Nick, BSc, M.B.B.S., MMed (Clin. Epi), PhD, FRACP

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)

    Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE) by Lee, Chee Khoon, PhD, Liao, Bin-Chi, MD, Subramaniam, Shalini, MMed (Clin Epi), Chiu, Chao-Hua, MD, Mersiades, Antony J., MMed (Clin Epi), Ho, Chao-Chi, MD, PhD, Brown, Chris, MBiostats, Lai, Chun-Liang, MD, PhD, Hughes, Brett G.M., M.B.B.S. (Hons), Yang, Tsung-Ying, MD, PhD, O’Byrne, Ken, MD, Luo, Yung-Hung, MD, PhD, Yip, Sonia, PhD, Ho, Ching-Liang, MD, Bray, Victoria, PhD, Su, Wu-Chou, MD, PhD, Moore, Melissa, PhD, Feng, Wei-Lien, MS, Bai, Ya-Ying, MS, Ford, Kate, MHSc, Cummins, Michelle M., PhD, Stockler, Martin R., MSc (Clin Epi), Solomon, Benjamin J., PhD, John, Thomas, PhD, Chih-Hsin Yang, James, MD, PhD

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: